Welcome to Morningstar

Type Ticker, Company or Fund Name

Sign Up My Account

Close
Login Log out

Keep me signed in.

Forgot your password?

Not already a member? Click here to register.

Logging in...

Close
Company Site

Smith & Nephew PLC SN.

Last Price
794.50

Day Change
5.50|0.70%

As of 22/05/2013
16:43:46 BST | GBX Minimum 15 Minutes Delay.

Bid/Offer	Day Range	Volume	90d Ave Vol	Mkt Cap
793.50 - 795.50	783.50 - 798.50	1,845,937	-	7,149.381

Last Close	52 Week Range	P/E	Yield %	ISIN
789.00	567.50 - 798.50	14.37	1.64	GB0009223206

Smith & Nephew Share Price

more...

Morningstar's Take SN.

Smith & Nephew faces tough competitors in its chosen fields, but we think its devices offer compelling value propositions. The firm operates with two major segments: advanced surgical devices (a combination of the former orthopedic and endoscopy units) and advanced wound management.

Fair Value Estimate

720.00 GBX

Uncertainity

Average

Economic Moat

Narrow

Total Returns

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	0.70
FTSE 100 TR GBP	0.71

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	10.50
FTSE 100 TR GBP	8.72

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	13.96
FTSE 100 TR GBP	9.38

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	37.03
FTSE 100 TR GBP	33.08

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	10.62
FTSE 100 TR GBP	14.31

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	8.86
FTSE 100 TR GBP	5.77

	Chg (%)
3yr, 5yr & 10yr performance data is annualised.

Smith & Nephew PLC	8.92
FTSE 100 TR GBP	9.50

Financials
	Annual
	2010	2011	2012
more...
Income Statement
Turnover	2,530.50	2,747.57	2,545.06
Operating Profit	587.60	554.66	520.46
Net Profit	392.80	374.49	448.48
Reported EPS	44.20	41.83	49.77
Balance Sheet
Current Assets	1,375.74	1,338.39	1,318.98
Non Current Assets	1,647.19	1,635.67	2,151.95
Total Assets	3,022.93	3,054.50	3,470.93
Current Liabilities	583.76	732.26	572.13
Total Liabilities	1,251.84	1,003.80	1,081.51
Total Equity	1,771.09	2,050.71	2,389.42
Cash Flow
Cash From Operations	709.59	730.33	728.39
Change in Net Cash	9.58	-21.23	1.23

Broker Forecasts
Year Ending	Pre-tax	EPS	EPSg	P/E	PEG	DPS	Yld %
more...
'Broker Forecasts' provides consensus figures based on several brokers' views
2013	631.85	49.93	-9.69	15.80	-1.63	17.37	2.20
2014	697.41	55.61	11.39	14.19	1.25	19.13	2.43

Regulatory News

Date	Source	Headline
more...
21/05/13\|18:00	RNS	Smith & Nephew Plc - Transaction in Own Shares
20/05/13\|17:56	RNS	Smith & Nephew Plc - Transaction in Own Shares
20/05/13\|08:53	RNS	Smith & Nephew Plc - Additional Listing

Date	Source	Headline
more...
02/05/13\|07:41	DJ	DJ Smith & Nephew 1Q Net Pft $143M
02/05/13\|07:13	DJ	DJ Smith & Nephew To Buy Indian Trauma Business For Undisclosed Sum
02/05/13\|07:01	DJ	DJ Smith & Nephew Plc Smith & Nephew to acquire Indian trauma business

Date	Author	Headline
10/12/2012	Alanna Petroff	StanChart & Greggs Stand Out on FTSE MONDAY MARKET UPDATE: Companies such as Standard Chartered and Greggs grabbed headlines in the UK, but overall, the FTSE was relatively flat on Monday
14/11/2011	Julie Stralow, CFA	Orthopaedic Device Makers Take a Step Back Competitive advantages appear to be weakening, says Morningstar analyst Julie Stralow
04/10/2011	Julie Stralow, CFA	Government Spending and Orthopaedic Device Firms Significant uncertainty about fiscal budgets and capital spending at hospitals leads us to place orthopaedic device firms under review

Director Dealings
Traded	Action	Notifier	Price	Amount	Value
more...
08/05/2013	in Lieu of Dividend	Sir John Buchanan	759.85	2,247	17,074.00
08/05/2013	in Lieu of Dividend	Olivier Bohuon	759.85	511	3,883.00
02/04/2013	Sale	Olivier Bohuon	763.08	16,689	127,350.00
02/04/2013	Transfer in	Olivier Bohuon	0.00	66,667	0.00

Company Profile

Smith & Nephew PLC develops, manufactures, markets and sells medical devices in the sectors of Orthopaedics, Endoscopy and Advanced Wound Management. Its three operating segments are Orthopaedics, Endoscopy and Advanced Wound Management.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

10500

Outlook

(02/05/2013) "We see the outlook for the group as a whole for 2013 as unchanged from the view which we set out with our 2012 Full Year Results in February"

Next Event 02/08/2013

Next interim announcement

Ratios
	Comp	Sec	Mkt

PER (E)	15.14	14.55	14.26
Div Yld (E)	2.29	2.24	3.59
PEG (E)	-7.19	-5.19	0.43
ROCE	47.78	38.17	-0.32
Op Mrgn	22.35	-17.58	-55.37
EPS Grwth	-2.11	-0.71	17.85

Dividends
	Previous	Latest
more...
Declared Date	12/10/12	19/04/13
Ex-Div	10/10/12	17/04/13
Paid	30/10/12	08/05/13
Amnt p	6.31	10.60

Broker Forecasts

Strong Buy	0
Buy	4
Hold	3
Sell	2
Strong Sell	0

Strong Sell
Strong Buy